Xenon Pharmaceuticals XENE
NASDAQ XENE
$41.39 +0.94 (+2.32%)
At close: Nov 10, 2026 · 4:00 PM EST

Xenon Pharmaceuticals (XENE) EV to EBIT (2014 - 2015)

Updated

Xenon Pharmaceuticals' (XENE) EV to EBIT was 32.92 for Q2 2015, down 21.2% from the prior quarter.

Analysis

Xenon Pharmaceuticals (XENE) EV to EBIT (2014 - 2015) Analysis & Trends

Over the twelve months ended Jun 30, 2015, Xenon Pharmaceuticals' EV to EBIT came in at -42.26; for FY2014, it was -1.94.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Xenon Pharmaceuticals 4.06 Bn 1.03 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2015 32.92
Mar 31, 2015 41.76
Dec 31, 2014 -1.94
API Access

Xenon Pharmaceuticals EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=XENE&period=max&api_key=YOUR_API_KEY